These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35174182)
41. Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention. Wu H; Sun Z; Tong L; Wang Y; Yan H; Sun Z Arch Osteoporos; 2021 Oct; 16(1):154. PubMed ID: 34632530 [TBL] [Abstract][Full Text] [Related]
42. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography. Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817 [TBL] [Abstract][Full Text] [Related]
43. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Sho K; Takahashi K; Yamada H; Wada M; Nagai Y; Otsuji T; Nishikawa M; Mitsuma Y; Yamazaki Y; Matsumura M; Uyama M Arch Ophthalmol; 2003 Oct; 121(10):1392-6. PubMed ID: 14557174 [TBL] [Abstract][Full Text] [Related]
44. One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy. Medina-Baena M; Huertos-Carrillo MJ; Rodríguez L; García-Pulido JI; Cornejo-Castillo C; Calandria-Amiguetti JM Case Rep Ophthalmol; 2018; 9(1):172-178. PubMed ID: 29681832 [TBL] [Abstract][Full Text] [Related]
45. Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Bessho H; Kondo N; Honda S; Kuno S; Negi A Mol Vis; 2009 Jun; 15():1107-14. PubMed ID: 19503741 [TBL] [Abstract][Full Text] [Related]
46. ANGIOGRAPHIC SUBTYPES OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN TAIWAN: A Prospective Multicenter Study. Yeung L; Kuo CN; Chao AN; Chen KJ; Wu WC; Lai CH; Wang NK; Hwang YS; Chen CL; Lai CC Retina; 2018 Feb; 38(2):263-271. PubMed ID: 28196060 [TBL] [Abstract][Full Text] [Related]
47. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy. Komuku Y; Iwahashi C; Gomi F Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935 [TBL] [Abstract][Full Text] [Related]
48. Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization. Tso MOM; Suarez MJ; Eberhart CG Am J Ophthalmol Case Rep; 2018 Sep; 11():176-180. PubMed ID: 30128371 [TBL] [Abstract][Full Text] [Related]
49. Anti-VEGF Therapy for Neovascular AMD and Polypoidal Choroidal Vasculopathy. Cheung GCM; Lai TYY; Gomi F; Ruamviboonsuk P; Koh A; Lee WK Asia Pac J Ophthalmol (Phila); 2017; 6(6):527-534. PubMed ID: 28971633 [TBL] [Abstract][Full Text] [Related]
50. Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy. Park UC; Shin JY; Chung H; Yu HG BMC Ophthalmol; 2017 Dec; 17(1):241. PubMed ID: 29212537 [TBL] [Abstract][Full Text] [Related]
51. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Tanaka K; Nakayama T; Mori R; Sato N; Kawamura A; Mizutani Y; Yuzawa M Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7441-4. PubMed ID: 21896867 [TBL] [Abstract][Full Text] [Related]
52. Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Subhi Y; Krogh Nielsen M; Molbech CR; Krüger Falk M; Singh A; Hviid TVF; Nissen MH; Sørensen TL JAMA Ophthalmol; 2019 May; 137(5):515-522. PubMed ID: 30844038 [TBL] [Abstract][Full Text] [Related]
53. Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study. Yeung L; Lai CC; Chen SN; Cheng CK; Yang CM; Hsieh YT; Tsai A; Yang CH Sci Rep; 2021 Jan; 11(1):470. PubMed ID: 33432090 [TBL] [Abstract][Full Text] [Related]
54. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Maruko I; Iida T; Saito M; Nagayama D Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):361-8. PubMed ID: 20072785 [TBL] [Abstract][Full Text] [Related]
55. EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Tan CS; Ngo WK; Lim LW; Tan NW; Lim TH; Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1923-1930. PubMed ID: 27142805 [TBL] [Abstract][Full Text] [Related]
56. Polypoidal choroidal vasculopathy - a type I polypoidal subretinal neovasculopathy. Kokame GT Open Ophthalmol J; 2013; 7():82-4. PubMed ID: 24265653 [TBL] [Abstract][Full Text] [Related]
57. Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images. Bakthavatsalam M; Ng DS; Lai FH; Tang FY; Brelén ME; Tsang CW; Lai TY; Cheung CY Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):935-943. PubMed ID: 28150038 [TBL] [Abstract][Full Text] [Related]